Pages that link to "Item:Q2242847"
From MaRDI portal
The following pages link to On optimal subset designs for phase II clinical trials with both total response and disease control (Q2242847):
Displaying 5 items.
- Efficient designs for phase II oncology trials with ordinal outcome (Q1708948) (← links)
- Optimizing randomized trial designs to distinguish which subpopulations benefit from treatment (Q3107976) (← links)
- An optimal Bayesian predictive probability design for phase II clinical trials with simple and complicated endpoints (Q3299101) (← links)
- Adaptive Two-Stage Designs for Single-Arm Phase IIA Cancer Clinical Trials (Q3442979) (← links)
- Optimal two-stage designs for phase ii clinical trials with differentiation of complete and partial responses (Q4550632) (← links)